In February, the journal Vaccine temporarily removed the study without explanation, and told the authors the editor had asked for further review. Later that month, Vaccine retracted the paper, citing “serious concerns regarding the scientific soundness of the article,” and “seriously flawed” methodology.
In July, another journal — Immunologic Research — republished the paper.
As we previously reported, the previous version of the paper, “Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil,” (which has been removed entirely by Vaccine), said:
It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes.
The new paper in Immunologic Research, “Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil,” contains the same sentence in its abstract.
Furthermore, in the new version of the study, the authors conclude:
…both Al and Gardasil vaccine injections resulted in behavioral abnormalities in mice…
As we previously reported, Shaw and another co-author of the paper, Lucija Tomljenovic (also at UBC), have previously published a study that suggested that aluminium in vaccines is linked to autism; subsequently, a World Health Organization advisory body concluded that this study (and another by the pair) were “seriously flawed.”